30Apr
Vaporising cannabis cuts harmful toxins by 99% compared to smoking, study finds
Research conducted by vaporiser manufacturer PAX suggests dry herb vaping dramatically reduces exposure to toxic compounds found in cannabis smoke.
27Apr
Review: Pipe Dreams and Smoke Screens – A Memoir of Hashish Adventures in the Sixties
Richard Halford’s brilliantly written, authentic and riveting memoir exploring how he spent the sixties making, smuggling and dealing high-quality Moroccan...
08Apr
German cannabis legalisation shows mostly positive results, government report finds
The black market has shrunk, police investigations are restricted, youth use remains stable, and the medical cannabis industry has become...
05Apr
Heavy use of vape cartridges linked to Cannabis Hyperemesis Syndrome, new study finds
University of California researchers found that vaping THC cartridges may trigger earlier onset of the debilitating condition, which causes severe...
27Mar
Medical cannabis provides anxiety relief for 94% of patients, study finds
A 45-day study tracking over 400 medical cannabis patients in Florida found that the vast majority experienced significant reductions in...
23Mar
Psilocybin six times more effective at helping people quit smoking than nicotine patches
A single dose of psilocybin combined with therapy helped 41% of participants quit smoking for six months, compared to just...
20Mar
Ketamine use up, MDMA use down latest wastewater analysis shows
Europe's largest wastewater drug study reveals a sharp 16% drop in MDMA traces across the continent, while ketamine use soars...
14Mar
CBD and CBG promising treatments for fatty liver disease, a new study finds
Research showed that the two non-psychoactive cannabinoids assisted the liver by improving blood sugar control and reducing harmful fat buildup.
08Mar
Cannabis use not linked to cognitive decline or dementia in older adults, study finds
Oxford University researchers found no evidence that cannabis use accelerates cognitive decline or increases dementia risk in later life, according...
05Mar
Psilocybin could combat post-treatment Lyme disease, new study finds
Johns Hopkins study finds significant improvements in symptom burden and quality of life lasting up to six months after treatment...
